![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Two related series of PDE7 inhibitors with sub-micromolar potency are claimed. These are N-phenyl-3-benzoxazol-2-ylphenylsulfonamide and N-phenyl-3-benzimidazol-2-ylphenylsulfonamide derivatives. These represent the fourth series of PDE7 inhibitors described to date and may be useful in the treatment of asthma and allergic diseases, via modulation of T cell function.